Canakinumab biosimilar(Alvotech)
卡那奴单抗单抗生物类似药（Alvotech）
Report date: 2025/10/10 15:37:18
Base Information
Drug NameCanakinumab biosimilar(Alvotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlvotech hf
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A